Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

ABA: Merger Practice Workshop

Summary

Related Content

FTC and DOJ Finalize Major Changes to HSR Form and Disclosure Requirements

The General Court of the European Union Annuls a €1.5 Billion Fine Against Google AdSense

FTC Escalates Battle Against PBMs With Complaint on Insulin Pricing

Antitrust & Competition Healthcare Quarterly Update Q2 2024

UK National Security and Investment Regime: Government Publishes Latest Annual Report

Reliance on Third-Party “Pricing” Facilitators Under Increasing Antitrust Scrutiny

Five Steps Hotel Owners, Operators, and Management Companies Can Take to Mitigate Risk in the Face of Heightened Antitrust Scrutiny and a Wave of Lawsuits Involving Revenue-Management Tools

In a Landmark Judgment, Top European Court Curbs European Commission’s Ability to Review “Killer Acquisitions”

Benchmark Litigation US 2025 Recognizes 45 Goodwin Litigators

Goodwin Advises Curon Biopharmaceutical in Acquisition of CN201 by Merck for $700 Million Upfront Plus up to $600 Million Milestones

The Legal 500 UK 2025 Recognizes 26 Practices and 39 Lawyers Across Goodwin’s UK Platform

Goodwin Names 35 New Partners

Markforged To Be Acquired By Nano Dimension In $115 Million All Cash Transaction

MultiPlan Defense Amid Price-Fixing Scrutiny Gets Boost in Court (Bloomberg Law)

Benchmark Litigation Names Fourteen Goodwin Partners to 40 & Under Hot List 2024

Avoiding Antitrust Pitfalls: Practical Pointers for Public Companies

Antitrust & Competition